ScienceDaily: Health & Medicine News |
- Concussion secrets unveiled in mice and people
- Flipping a gene switch reactivates fetal hemoglobin, may reverse sickle cell disease
- Gene promotes one in a hundred of tumors: Gene discovered to play a part in one per cent of all cancers
- Gene expression changes with meditation
- International gene therapy trial for 'bubble boy' disease shows promising early results
| Concussion secrets unveiled in mice and people Posted: 08 Dec 2013 10:36 AM PST There is more than meets the eye following even a mild traumatic brain injury. While the brain may appear to be intact, new findings suggest that the brain's protective coverings may feel the brunt of the impact.  |
| Flipping a gene switch reactivates fetal hemoglobin, may reverse sickle cell disease Posted: 08 Dec 2013 10:36 AM PST Hematology researchers have manipulated key biological events in adult blood cells to produce a form of hemoglobin normally absent after the newborn period. Because fetal hemoglobin is unaffected by the genetic defect in sickle cell disease, these cell culture findings may open the door to a new therapy for the debilitating blood disorder.  |
| Posted: 08 Dec 2013 10:35 AM PST Researchers have identified a gene that drives the development of tumors in over one per cent of all cancer patients. This is the first time that the gene CUX1 has been broadly linked to cancer development.  |
| Gene expression changes with meditation Posted: 08 Dec 2013 06:03 AM PST With evidence growing that meditation can have beneficial health effects, scientists have sought to understand how these practices physically affect the body. A new study reports the first evidence of specific molecular changes in the body following a period of mindfulness meditation.  |
| International gene therapy trial for 'bubble boy' disease shows promising early results Posted: 08 Dec 2013 06:03 AM PST Researchers reported promising outcomes data for the first group of boys with X-linked severe combined immunodeficiency syndrome, a fatal genetic immunodeficiency also known as "bubble boy" disease, who were treated as part of an international clinical study of a new form of gene therapy. Its delivery mechanism was designed to prevent the leukemia that arose a decade ago in a similar trial in Europe.  |
| You are subscribed to email updates from ScienceDaily: Health & Medicine News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
ليست هناك تعليقات:
إرسال تعليق